Incidence of tuberculosis in patients receiving anti-TNF therapy for rheumatic diseases: a systematic review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Incidence of tuberculosis in patients receiving anti-TNF therapy for rheumatic diseases: a systematic review
Authors
Keywords
-
Journal
CLINICAL RHEUMATOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-03
DOI
10.1007/s10067-019-04866-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of tuberculosis in patients treated with TNF-α antagonists: a systematic review and meta-analysis of randomised controlled trials
- (2017) Zheng Zhang et al. BMJ Open
- Incidência de tuberculose em pacientes com artrite reumatoide em uso de bloqueadores do TNF no Brasil: dados do Registro Brasileiro de Monitoração de Terapias Biológicas BiobadaBrasil
- (2017) Claudia Leiko Yonekura et al. Revista Brasileira De Reumatologia
- The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan
- (2017) Chong Hong Lim et al. PLoS One
- AB0337 Incidence Rate of Tuberculosis in Rheumatoid Arthritis Patients Treated with TNF-α Inhibitors-Data from The Slovenian National bioRx.si Registry: Table 1
- (2016) Ž. Rotar et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of developing active tuberculosis in rheumatoid arthritis patients on adalimumab in Japan
- (2016) A. Watanabe et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor- Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence
- (2016) B. Kisacik et al. JOURNAL OF RHEUMATOLOGY
- Different Risk of Tuberculosis and Efficacy of Isoniazid Prophylaxis in Rheumatoid Arthritis Patients with Biologic Therapy: A Nationwide Retrospective Cohort Study in Taiwan
- (2016) Tsai-Ling Liao et al. PLoS One
- A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study
- (2016) Y-M Chiu et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis
- (2016) Proton Rahman et al. BMJ Open
- One-Year Tuberculosis Risk in Rheumatoid Arthritis Patients Starting Their First Tumor Necrosis Factor Inhibitor Therapy from 2008 to 2012 in Taiwan: A Nationwide Population-Based Cohort Study
- (2016) Chong-Hong Lim et al. PLoS One
- Risk of tuberculosis in patients treated with anti-tumor necrosis factor therapy: a nationwide study in South Korea, a country with an intermediate tuberculosis burden
- (2015) Seung Min Jung et al. International Journal of Rheumatic Diseases
- The Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor- Antagonist: A Metaanalysis of Both Randomized Controlled Trials and Registry/Cohort Studies
- (2015) J.-W. Ai et al. JOURNAL OF RHEUMATOLOGY
- Incidence of active mycobacterial infections in Brazilian patients with chronic inflammatory arthritis and negative evaluation for latent tuberculosis infection at baseline - A longitudinal analysis after using TNFa blockers
- (2015) Carina Mori Frade Gomes et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Tuberculosis in pediatric patients treated with anti-TNFα drugs: a cohort study
- (2015) Joan Calzada-Hernández et al. Pediatric Rheumatology
- Risk of Tuberculosis in Children with Juvenile Idiopathic Arthritis: A Nationwide Population-Based Study in Taiwan
- (2015) Yi-Chen Hsin et al. PLoS One
- Factors Affecting the Tuberculosis Risk in Patients Receiving Anti-Tumor Necrosis Factor-α Treatment
- (2015) Sermin Borekci et al. RESPIRATION
- Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.pt
- (2015) Ana F. Mourão et al. RHEUMATOLOGY
- FRI0414 The risk of tuberculosis in patients with ankylosing spondylitis during anti-tnf therapy: data from national database in slovakia
- (2014) M. Zlnay et al. ANNALS OF THE RHEUMATIC DISEASES
- Mycobacterial diseases developed during anti-tumour necrosis factor- therapy
- (2014) J.-W. Yoo et al. EUROPEAN RESPIRATORY JOURNAL
- Tuberculosis risk and anti-tumour necrosis factor agents in rheumatoid arthritis: a critical appraisal of national registry data
- (2014) Rossana Scrivo et al. International Journal of Rheumatic Diseases
- Risk of tuberculosis, serious infection and lymphoma with disease-modifying biologic drugs in rheumatoid arthritis patients in Taiwan
- (2014) Ying-Ming Chiu et al. International Journal of Rheumatic Diseases
- High Incidence of Tuberculosis Infection in Rheumatic Diseases and Impact for Chemoprophylactic Prevention of Tuberculosis Activation during Biologics Therapy
- (2013) Dongyi He et al. Clinical and Vaccine Immunology
- Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden area
- (2013) Hye Won Kim et al. CLINICAL RHEUMATOLOGY
- Factors associated with withdrawal of the anti-TNFα biologics in the treatment of rheumatic diseases: data from the Hong Kong Biologics Registry
- (2013) Chi Chiu Mok et al. International Journal of Rheumatic Diseases
- Risk of tuberculosis with anti-tumor necrosis factor-α therapy: substantially higher number of patients at risk in Asia
- (2013) Sandra V. Navarra et al. International Journal of Rheumatic Diseases
- Risk of tuberculosis in rheumatoid arthritis patients on tumour necrosis factor-alpha inhibitor treatment in Taiwan
- (2013) W-M. Ke et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Mycobacterial Infections in Patients Treated with Tumor Necrosis Factor Antagonists in South Korea
- (2013) Sang Kook Lee et al. LUNG
- PReS-FINAL-2265: Tuberculosis in pediatric patients who are receiving anti-TNF agents
- (2013) J Calzada-Hernández et al. Pediatric Rheumatology
- PReS-FINAL-2019: Tuberculosis infection observed in patients receiving biological DMARDs for treatment of juvenile idiopathic arthritis
- (2013) A Sarychev et al. Pediatric Rheumatology
- Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis
- (2013) Kyung-Wook Jo et al. RESPIRATORY MEDICINE
- The frequency of tuberculosis chemoprophylaxis prior to TNF-α inhibitor treatment, and the incidence tuberculosis infection using a two-step screening algorithm for latent tuberculosis infection: data from the BioRx.si registry
- (2012) Matija Tomšič et al. ANNALS OF THE RHEUMATIC DISEASES
- Mycobacterial diseases and antitumour necrosis factor therapy in USA
- (2012) KL Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and Efficacy of Etanercept in a Cohort of Patients with Juvenile Idiopathic Arthritis Under 4 Years of Age
- (2012) C. BRACAGLIA et al. JOURNAL OF RHEUMATOLOGY
- Incidence of Tuberculosis Among Korean Patients with Ankylosing Spondylitis Who Are Taking Tumor Necrosis Factor Blockers
- (2011) EUN-MI KIM et al. JOURNAL OF RHEUMATOLOGY
- Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry
- (2011) María José Pérez-Sola et al. MEDICINA CLINICA
- Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients
- (2011) Christiane Aguiar Nobre et al. RHEUMATOLOGY INTERNATIONAL
- Is it safe to use anti-TNF-α agents for tuberculosis in children suffering with chronic rheumatic disease?
- (2011) Omer Kilic et al. RHEUMATOLOGY INTERNATIONAL
- 2.3. Rheumatoid arthritis - anti-TNFα therapy
- (2010) International Journal of Rheumatic Diseases
- ABSTRACTS OF THE33RD SCANDINAVIAN CONGRESS OF RHEUMATOLOGY Bergen, Norway, May9th – 12th, 2010
- (2010) SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
- (2009) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry
- (2009) F. Tubach et al. ARTHRITIS AND RHEUMATISM
- Años potenciales de vida perdidos por cáncer oral en el Área Sanitaria Centro de la provincia de Lugo
- (2009) Pablo I. Varela Centelles et al. Atencion Primaria
- Infectious complications of biological therapy
- (2009) Nigil Haroon et al. CURRENT OPINION IN RHEUMATOLOGY
- Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis
- (2009) Tulin Cagatay et al. RHEUMATOLOGY INTERNATIONAL
- Serious infections during anti-TNFα treatment in rheumatoid arthritis patients
- (2008) Ennio Giulio Favalli et al. AUTOIMMUNITY REVIEWS
- Increased risk of tuberculosis in patients treated with antitumor necrosis factor alpha
- (2008) Osman Elbek et al. CLINICAL RHEUMATOLOGY
- Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention
- (2008) C. Garcia-Vidal et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started